斯洛伐克肺炎菌株抗宏化物耐药性增加可能与宏化物消费增加有关

Peter Kunč1, Jaroslav Fábry1, Katarina Ištvánková1

  • 1Clinic of Paediatric Respiratory Diseases and Tuberculosis, National Institute of Paediatric Tuberculosis and Respiratory Diseases, Dolny Smokovec, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.

概括

在斯洛伐克,宏类抗生素的使用率很高,反映了小儿学Streptococcus pneumoniae菌株的耐药性增加. 迫切需要对抗生素管理,以对抗这种公共卫生威胁.